Articles

This Guest Column appeared in Drug Store News | June 8, 2026 By Stephen Beckman, CEO.

In this Drug Store News article several pharmaceutical company executives were asked about the greatest areas of opportunity, how their organizations are positioning to capitalize on them and what changes they believe are necessary to build a more resilient, patient-focused generics ecosystem.

(NAPS)—An estimated 20 million Americans have some form of thyroid disease.1 During January, recognized as Thyroid Awareness Month, YARAL Pharma is raising awareness of thyroid disease, particularly hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormone. Despite its prevalence, thyroid disease remains widely misunderstood, with many people unaware of its

RxInsider has long been a trusted resource for pharmacy professionals—educating pharmacy management and market professionals on the products, services, and trends that impact pharmacy operations across the supply chain.  At YARAL Pharma, supporting pharmacy and pharmacists is central to how we do business—from building a reliable, high-quality generics portfolio to partnering closely with customers to

This Article appeared in DSN | December 3, 2025 Read complete article on Drug Store News Generic and biosimilar medicines created $467 billion in savings for patients and the overall healthcare system in 2024, according to The Association for Accessible Medicines’ 2024 U.S. Generic & Biosimilar Medicines Saving Report. The report also noted that generics and

This Article appeared in NAPS | December 4, 2025 (NAPSI)—If you’ve ever dealt with acute pain, whether from a sports injury, a sudden sprain, or everyday strain, you know how much it can interfere with your life. Finding a safe, effective pain relief option can be challenging. Prescription topical pain patches are applied directly to the

This Interview appeared in DSN | August 21, 2025 Watch the interview here on Drug Store News In this latest edition of Watch DSN, publisher John Kenlon caught up with with Stephen Beckman, CEO of Yaral Pharma, to discuss the evolving role of generics in healthcare.  Beckman explained that although generics make up 90% of prescriptions, the

YARAL Pharma Launches Diclofenac Epolamine Topical System 1.3% Jan 3, 2023 Authorized Generic of Flector® Now Available. Read the entire article at Pharmacy Times